The proposed genomic surveillance for SARS CoV 2 In India is aimed at sustained detection of mutations in the viral genome from samples from all regions in India. Genomic Surveillance for SARS CoV 2 In India Indian SARS CoV 2 Genomics Consortium INSACOGG

This program will accelerate the translation of genomic data into clinical and public health research and interventions By allowing a more comprehensive and accurate detection of COVID 19 lineages from clinical and surveillance samples the genomic technologies and epidemiologic and bioinformatic tools will 1 expand our knowledge of virus at the molecular and clinical level 2 allow faster characterization of emerging lineages and assist with the surveillance of those viruses and 3 accelerate the development of NGS technology in the country for future use in diagnostic assays and tracking transmission dynamics of COVID 19 and other viruses